SEC FORM 4
$457,000.32
UNITED THERAPEUTICS Corp (UTHR)
Sale of 840 shares at $544.048 per share.
Reporting Person ROTHBLATT MARTINE A · Officer Title Chairperson & CEO · Transaction Code S
Traded Sep 30, 2026 · Disclosed Oct 1, 2026
Source: SEC Form 4 · 0001106578-26-000153 · filed 2026-10-01 · View filing →